Key Documents
Lawrence Steinman
Academic Appointments
- Professor, Neurology & Neurological Sciences
- Professor, Pediatrics
- Professor (By courtesy), Genetics
Contact Information
-
Clinical Offices
Neurology Clinic 300 Pasteur Dr A301 MC 5325 Stanford, CA 94305 Tel Work (650) 723-6469 Fax (650) 725-0390Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
-
Academic Offices
Personal Information EmailNot for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Neurology
- Neurology, Pediatric
- Multiple Sclerosis, Myasthenia Gravis, Immune Disorders
Administrative Appointments
- Chairman, Interdepartmental Program in Immunology, Interdepartmental Program in Immunology, Stanford University (2002 - 2009)
Honors and Awards
- Friedrich Sasse Prize, Free Univ.of Berlin (1994)
- Sen. Jacob Javits Award, US Congress (1988-2002)
- John M. Dystel Prize, American Academy of Neurology and National MS Society (2004)
Professional Education
| Board Certification: | Neurology, American Board of Psychiatry and Neurology (1984) |
| Residency: | SUMC - Graduate Medical Education, CA (1980) |
| Fellowship: | National Institute of Health, MD (1977) |
| Fellowship: | Weizmann Institute Of Science, Israel (1977) |
| Residency: | SUMC - Graduate Medical Education, CA (1974) |
Postdoctoral Advisees
Robert Axtell, Katja Herges, Hedwich Kuipers, Michael Kurnellas, Brigit de Jong
Graduate & Fellowship Program Affiliations
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information
| Consulting: | Bayhill Therapeutics, Peptimmune, NuonTherapeutics, Cardinal, Glaxo Smith Kline |
| Equity: | Bayhill Therapeutics, Peptimmune, NuonTherapeutics, Cardinal, Glaxo Smith Kline |
| Service on Board of Directors: | Bayhill Therapeutics, Peptimmune, NuonTherapeutics, Cardinal, Glaxo Smith Kline |
Scientific Focus
Research Interests
Our laboratory is dedicated to understanding the pathogenesis of autoimmune diseases, particularly multiple sclerosis. We have developed several new therapies for autoimmunity, including some in Phase 2 clinical trials, as well as one approved drug, natalizumab. We have developed microarray technology for detecting autoantibodies to myelin proteins and lipids. We employ a diverse range of molecular and celluar approaches to trying to understand multiple sclerosis.
Publications
- PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat Med. 2009; (11): 1266-72
- Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc Natl Acad Sci U S A. 2009; (35): 14948-53
- A molecular trio in relapse and remission in multiple sclerosis. Nat Rev Immunol. 2009; (6): 440-7
- Innate and adaptive autoimmunity directed to the central nervous system. Neuron. 2009; (1): 123-32
- A rush to judgment on Th17. J Exp Med. 2008; (7): 1517-22
Help